FindTrial
Sign In

p130cas suggests a poor prognosis for non-small cell lung cancer by regulating the formation and maturation of tertiary lymphoid structures

p130cas suggests a poor prognosis for non-small cell lung cancer by regulating the formation and maturation of tertiary lymphoid structures

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110657
Enrollment
Unknown
Registered
2025-10-17
Start date
2025-10-20
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NSCLC

Interventions

Observation group:None

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 75 Years

Inclusion criteria

Inclusion criteria: Eligible research participants selected for this study must meet all of the following criteria: (1) The patient's pathological diagnosis is non-small cell lung cancer, including adenocarcinoma in situ, minimally invasive adenocarcinoma and invasive adenocarcinoma. (2) The first occurrence of non-small cell lung cancer without any treatment, including targeted drug therapy.

Exclusion criteria

Exclusion criteria: Research participants who meet any of the following criteria are not eligible for inclusion in this study: (1) Over 75 years old with serious diseases of other systems. (2) The patient has a history of other neoplastic diseases.

Design outcomes

Primary

MeasureTime frame
p130cas;—

Countries

China

Contacts

Public ContactjingduoLi

Shanghai General Hospital

jingduoli0402@163.com+86 189 4027 9759

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026